News & Updates

Aspirin may offer protection against GI cancer-related death in H pylori-free individuals

18 May 2024

For people who have successfully undergone Helicobacter pylori-eradication therapy, the use of aspirin does more good than harm, such that the benefit of reduced gastrointestinal (GI) cancer-related mortality outweighs the risk of bleeding-related mortality, according to a study.

Aspirin may offer protection against GI cancer-related death in H pylori-free individuals

18 May 2024

Two-year data support brolucizumab for diabetic macular oedema

17 May 2024 by

The 100-week results of the phase III KESTREL and KITE studies reflect the long-term efficacy and durability of brolucizumab in improving visual and anatomical outcomes in patients with diabetic macular oedema (DMO).

Two-year data support brolucizumab for diabetic macular oedema

17 May 2024

Menopausal hormone therapy may protect against gastric cancer in Asians

16 May 2024 by

The use of menopausal hormone therapy among postmenopausal Asian women has been linked to a reduced risk of gastric cancer in a study.

Menopausal hormone therapy may protect against gastric cancer in Asians

16 May 2024

Selective aldose reductase inhibitor for DCM disappoints in trial

16 May 2024

Treatment with AT-001, a highly selective aldose reductase inhibitor, for 15 months seems no better than placebo in improving exercise capacity among individuals with diabetic cardiomyopathy (DCM) and impaired exercise capacity, a study has shown.

Selective aldose reductase inhibitor for DCM disappoints in trial

16 May 2024

Long-term data strengthen TAK-003 potential against dengue

16 May 2024 by

The live-attenuated tetravalent dengue vaccine TAK-003 showed cumulative long-term efficacy in preventing symptomatic dengue caused by all four dengue virus (DENV) serotypes among previously exposed children and adolescents, and by DENV-1 and DENV-2 in dengue-naïve participants in eight* dengue-endemic countries, a study has shown.

Long-term data strengthen TAK-003 potential against dengue

16 May 2024

Biologic DMARDs offer clinical benefits in adult-onset Still disease

15 May 2024 by

Use of biologic disease-modifying antirheumatic drugs (bDMARDs), particularly tocilizumab (TCZ), anakinra (ANK), and canakinumab (CNK), appears safe and effective in the treatment of adult-onset Still disease (AOSD), results of a systematic review and meta-analysis have shown.

Biologic DMARDs offer clinical benefits in adult-onset Still disease

15 May 2024

Sequential fosfomycin therapy beneficial in bacterial prostatitis caused by multidrug-resistant E coli

14 May 2024 by

Sequential treatment with the oral antibiotic fosfomycin appears to be safe and effective in the management of patients with acute bacterial prostatitis secondary to multidrug-resistant Escherichia coli, according to the phase IV FOS-PROST study.

Sequential fosfomycin therapy beneficial in bacterial prostatitis caused by multidrug-resistant E coli

14 May 2024

Positive antibiotic interactions for MRSA bacteraemia tied to lower 14-day mortality

14 May 2024 by

Patients with positive in-vitro antibiotic interactions with vancomycin or daptomycin plus an antistaphylococcal β-lactam for methicillin-resistant Staphylococcus aureus (MRSA) bacteraemia appear to have greater survival at 2 weeks, as shown in a post hoc analysis of the CAMERA-2* study.

Positive antibiotic interactions for MRSA bacteraemia tied to lower 14-day mortality

14 May 2024

Inappropriate pneumonia diagnosis common, potentially harmful for hospitalized older adults

14 May 2024

The frequency of inappropriate diagnosis of community acquired pneumonia (CAP) is relatively high among hospitalized adults, especially those who are older, have dementia, or present with altered mental status, according to a study. In such cases, a full-course antibiotic treatment may be detrimental.

Inappropriate pneumonia diagnosis common, potentially harmful for hospitalized older adults

14 May 2024

Postoperative antibiotics do little to improve outcomes in paediatric gangrenous appendicitis

13 May 2024

In children who have nonperforated appendicitis with gangrenous, suppurative, and exudative (GSE) findings, the use of antibiotics following appendectomy does not lower the risk of surgical site infection (SSI), as shown in a study.

Postoperative antibiotics do little to improve outcomes in paediatric gangrenous appendicitis

13 May 2024

News & Updates

Filter by Specialty:

Specialty:

Aspirin may offer protection against GI cancer-related death in H pylori-free individuals

Aspirin may offer protection against GI cancer-related death in H pylori-free individuals

Two-year data support brolucizumab for diabetic macular oedema

Two-year data support brolucizumab for diabetic macular oedema

Menopausal hormone therapy may protect against gastric cancer in Asians

Menopausal hormone therapy may protect against gastric cancer in Asians

Selective aldose reductase inhibitor for DCM disappoints in trial

Selective aldose reductase inhibitor for DCM disappoints in trial

Long-term data strengthen TAK-003 potential against dengue

Long-term data strengthen TAK-003 potential against dengue

Biologic DMARDs offer clinical benefits in adult-onset Still disease

Biologic DMARDs offer clinical benefits in adult-onset Still disease

Sequential fosfomycin therapy beneficial in bacterial prostatitis caused by multidrug-resistant E coli

Sequential fosfomycin therapy beneficial in bacterial prostatitis caused by multidrug-resistant E coli

Positive antibiotic interactions for MRSA bacteraemia tied to lower 14-day mortality

Positive antibiotic interactions for MRSA bacteraemia tied to lower 14-day mortality

Inappropriate pneumonia diagnosis common, potentially harmful for hospitalized older adults

Inappropriate pneumonia diagnosis common, potentially harmful for hospitalized older adults

Postoperative antibiotics do little to improve outcomes in paediatric gangrenous appendicitis

Postoperative antibiotics do little to improve outcomes in paediatric gangrenous appendicitis